Information Provided By: 
Fly News Breaks for May 4, 2016
GMED
May 4, 2016 | 08:04 EDT
UBS views Globus Medical as substantially undervalued and would use any weakness as a buying opportunity. The firm said the company's margin execution remains the best in class and sees its lumpy quarter as a "one off" event. UBS reiterated its Buy rating and $32 price target on Globus Medical shares.
News For GMED From the Last 2 Days
There are no results for your query GMED
